Jing Zhang

发表

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Peihui Wang, Chengjiang Gao, Yi Zheng, 2020, bioRxiv.

SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways

Peihui Wang, Chengjiang Gao, Yi Zheng, 2020, bioRxiv.

A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins

S. Teng, Dongxiao Liu, Qiyi Tang, 2020, bioRxiv.

Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling

Jincun Zhao, J. Cui, Yaoxing Wu, 2020, Signal Transduction and Targeted Therapy.

An antibody-based proximity labeling protocol to identify biotinylated interactors of SARS-CoV-2

L. Shang, Jian Wang, Peihui Wang, 2022, STAR Protocols.

Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity

Zhuanchang Wu, Lifen Gao, Chunhong Ma, 2021, Signal Transduction and Targeted Therapy.

Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7

Jincun Zhao, Xiaocui Li, Haoxian Zhou, 2021, Signal Transduction and Targeted Therapy.

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

P. Zhan, Xinyong Liu, Peihui Wang, 2022, Signal Transduction and Targeted Therapy.

Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Peng Zhan, Jing Zhang, Christophe Pannecouque, 2011, Bioorganic & medicinal chemistry.

The Interplay Between Pattern Recognition Receptors and Autophagy in Inflammation.

Xiao-qiang Yu, Peihui Wang, Jiang Li, 2019, Advances in experimental medicine and biology.

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity

Yuchen Liu, Linlin Liu, Jian Wang, 2021, Cell Chemical Biology.

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

Ze-Guang Han, J. Xie, S. Tao, 2020, Cellular & Molecular Immunology.

Mechanical activation of spike fosters SARS-CoV-2 viral infection

Qiming Sun, J. Lou, Peihui Wang, 2021, Cell Research.

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

Haibo Wu, Weiwei Xue, Peihui Wang, 2021, iScience.

SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist

Chengliang Zhu, Rongrong Hua, Kaitao Zhao, 2021, Journal of virology.

SARS-CoV-2 NSP12 Protein Is Not an Interferon-b Antagonist

Chengliang Zhu, Kaitao Zhao, Aixin Li, 2021 .

Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection

Li Wang, Peihui Wang, Yun Cheng, 2020, Journal of medical virology.

SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways

Peihui Wang, Chengjiang Gao, Yi Zheng, 2023, Journal of medical virology.

SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways

Jia-Yu Pan, Peihui Wang, Chengjiang Gao, 2023, Journal of medical virology.

Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.

E. De Clercq, P. Zhan, Xinyong Liu, 2011, Current medicinal chemistry.

SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways

Peihui Wang, Chengjiang Gao, Yi Zheng, 2021, Journal of medical virology.